cancer drug prices are about to change as the government caps trade margins at 30%, potentially saving patients ₹2,500 crore...
India
Indian pharma exporters are considering following Sun Pharma's lead on US MFN pricing. This strategy could help them bypass tariffs...
In this articleUnderstanding Therapy-Aligned AcquisitionsThe Importance of Tier 2-3 MarketsNovartis India's Expansion PlansImpact on the Pharmaceutical IndustryChallenges in Acquiring New...
